- Home
- Research
- Biopilot_Plant
- Pilot_Plant_Main_activities
The main area of activities is the pharmaceutical industry (human and veterinary), namely in the development of production processes for new vaccines, diagnostics and therapeutic products, as well as production of recombinant proteins for structural biology studies
Another relevant area of work is the agro industry, namely in the development of Probiotics and starter cultures.
Pilot Plant Track Record
-
Biopharmaceutical Products
Cephalosporin C - Optimization of production
Recombinant fusion protein for cancer therapy
Antibodies fragments for cancer therapy – optimization of production process using Pichia pastoris (methanol induced and constitutive expression)
Malaria proteases inhibitors -
Vaccine development
Recombinant proteins for use in subunits vaccines
Virus like particles (VLP's) candidate vaccines for HIV and Porcine Parvovirus
Bacterial vaccines for veterinary purposes (Canine Leptospirose, Strangles)
Mass production of endothelial cells for Cowdriose vaccine -
Diagnostics
Diagnostic prototype for HIV
Diagnostic prototype for Leishmania
Antibody fragment for cancer -
Cell and virus banking for Quality Control purposes (Bioassays)
-
Production and purification of proteins for Structure Function Research
Nuclear Receptors and their ligand bindings domains
Non glycosilated proteins from E.coli
Glycoproteins from animal cells
-
Starter Cultures for Biotechnological Processes
Leuconostoc oenus
Lactobacillus plantarum
Bacillus subtilis spores for use as probiotics
-
Liophilization of Medicinal and Aromatic Plants
